undamentalytics Newsletter
Sign in

Xencor Inc income statement

In fiscal 2025, Xencor Inc reported revenue of $126m, up 13.7% on the year before, operating income of −$178m (a -141.4% margin) and net income of −$91.9m, or −$1.24 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue1094641157123275165175110126105
Research and development527298119170193200254228239256
General and administrative1318222430394753616465
Operating income44−43−7914−7744−82−132−178−178−216
Interest expense000——006373227
Net interest income—49147151932——
Income before tax46−39−7027−6983−55−120−235−90−161
Income tax1−00000114232
Net income45−38−7027−6983−55−133−233−92−163
Diluted EPS$1.07−$0.82−$1.31$0.46−$1.21$1.37−$0.93−$2.20−$3.58−$1.24−$2.18
Diluted shares (average)42m47m54m58m57m60m60m61m65m74m75m
EBITDA46−41−7618−7151−74−121−166−167−206

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: KYMR vs XNCRSEPN vs XNCRAGIO vs XNCRSPRY vs XNCR

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Xencor Inc's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Xencor Inc.